May 9, 2019

It was announced by the National Institute for Health and Care Excellence (NICE) that ocrelizumab will be available for use on the NHS for early primary progressive MS, after previously being considered too expensive for its benefits. Following a petition launched by t...

Please reload

Featured Posts

Seated Yoga - Temporarily suspended until September

July 6, 2019

1/4
Please reload

Recent Posts

March 15, 2020

December 22, 2019

Please reload

Archive